Evaluation of heterocyclic steroids and curcumin derivatives as anti breast cancer agents: Studying the effect on apoptosis in MCF-7 breast cancer cells

被引:36
作者
Elmegeed, Gamal A. [1 ]
Yahya, Shaymaa M. M. [1 ]
Abd-Elhalim, Mervat M. [1 ]
Mohamed, Mervat S. [2 ,3 ]
Mohareb, Rafat M. [2 ]
Elsayed, Ghada H. [1 ]
机构
[1] Natl Res Ctr, Hormones Dept, Giza 12622, Egypt
[2] Cairo Univ, Dept Chem, Fac Sci, Cairo, Egypt
[3] Cairo Univ, Biochem Special, Fac Sci, Cairo, Egypt
关键词
Apoptotic genes; Breast cancer; Cytotoxicity; Heterocycles; Steroids; GROWTH-INHIBITION; CYCLIN D1; SURVIVIN; DEATH; P53; MEDIATOR;
D O I
10.1016/j.steroids.2016.08.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anticancer agents consisting of hybrid molecules are used to improve effectiveness and diminish drug resistance. The current study aimed to introduce newly synthesized hetero-steroids of promising anticancer effects. Besides, the pro-apoptotic effects of new compounds were investigated extensively. Several pyrimidino-, triazolopyrimidino-, pyridazino-, and curcumin-steroid derivatives were synthesized, elucidated and confirmed using the spectral and analytical data. The synthesized hetero-steroids, compounds 9, 10, 11, 12, 13, 14, 15, 18, 20, 21, 22 and 24, were tested for their cytotoxic effects versus human breast cancer cells (MCF-7) using neutral red supravital dye uptake assay. Compound 24 (IC50 = 18 mu M) showed more inhibitory influence on MCF-7 growth. Using QRT-PCR (Quantitative real time-polymerase chain reaction), CCND1, Survivin, BCL-2, CDC2, P21 and P53, genes expression levels were investigated. The study results disclose that compounds 4, 7, 18, 24 knocked down the expression levels of CCND1, Survivin, BCL-2 and CDC2. However, P21 and P53 were up-regulated by compounds 21, 22. This study introduced promising pro-apoptotic anticancer agents acting through the modulation of key regulators of apoptosis and cell cycle genes. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:80 / 89
页数:10
相关论文
共 46 条
[1]   P53 CONTROLS BOTH THE G(2)/M AND THE G(1) CELL-CYCLE CHECKPOINTS AND MEDIATES REVERSIBLE GROWTH ARREST IN HUMAN FIBROBLASTS [J].
AGARWAL, ML ;
AGARWAL, A ;
TAYLOR, WR ;
STARK, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8493-8497
[2]  
Alodeani E.A., 2014, Eur. J. Biomed. Pharm. Sci., V1, P504
[3]   The case for survivin as a regulator of microtubule dynamics and cell-death decisions [J].
Altieri, Dario C. .
CURRENT OPINION IN CELL BIOLOGY, 2006, 18 (06) :609-615
[4]   Validating survivin as a cancer therapeutic target [J].
Altieri, DC .
NATURE REVIEWS CANCER, 2003, 3 (01) :46-54
[5]  
[Anonymous], 1989, Eur J Biochem, V186, P429
[6]  
[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
[7]  
[Anonymous], 2014, INT J ADV CHEM, DOI DOI 10.14419/IJAC.V2I2.2661
[8]   CYCLIN D1 IS A NUCLEAR-PROTEIN REQUIRED FOR CELL-CYCLE PROGRESSION IN G(1) [J].
BALDIN, V ;
LUKAS, J ;
MARCOTE, MJ ;
PAGANO, M ;
DRAETTA, G .
GENES & DEVELOPMENT, 1993, 7 (05) :812-821
[9]   Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroids [J].
Bansal, Ranju ;
Thota, Sridhar ;
Karkra, Nalin ;
Minu, Maninder ;
Zimmer, Christina ;
Hartmann, Rolf W. .
BIOORGANIC CHEMISTRY, 2012, 45 :36-40
[10]   Synthesis and Biological Evaluation of 16E-Arylidenosteroids as Cytotoxic and Anti-aromatase Agents [J].
Bansal, Ranju ;
Guleria, Sheetal ;
Thota, Sridhar ;
Hartmann, Rolf Wolfgang ;
Zimmer, Christina .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2011, 59 (03) :327-331